DIGP - DigiPath, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1100
+0.0060 (+5.77%)
At close: 2:10PM EDT
Stock chart is not supported by your current browser
Previous Close0.1040
Open0.1035
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1000 - 0.1117
52 Week Range0.0850 - 0.3145
Volume32,123
Avg. Volume48,245
Market Cap5.297M
Beta (3Y Monthly)3.33
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswire

    GroSciences Initiates Beta-testing of Tru-Hemp ID In North Carolina and Vermont

    BOULDER, CO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Digipath, Inc. (DIGP), a leading independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that GroSciences, its wholly owned subsidiary, has successfully completed beta-testing of its “Tru-Hemp ID” kit. Under the 2018 Farm Bill that legalized hemp cultivation, hemp is defined as having less than 0.3% delta-9-THC by dry weight.  As a result, compliance with the 2018 Farm Bill is usually determined by analyzing the THC content of a particular plant sample.  Tru-Hemp ID offers a simpler method for determining the strain of a particular plant in the form of a genetic test.  A full analysis of all data collected thus far using the Tru-Hemp ID kit that correlates the genetic outcome of samples with their actual THC content will be forthcoming.

  • PR Newswire

    Digipath's GroSciences Moving Forward with Further Testing for its Patent Pending All-Natural, Plant-Derived Pesticide

    BOULDER, Colo., Aug. 14, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that its GroSciences division has successfully completed preliminary validation testing on its patent pending all-natural, plant-derived pesticide, TERPO+ Broadspectrum. The product could potentially serve an enormous market by protecting cannabis plants against colonization by microorganisms. The testing has also shown that TERPO+ Broadspectrum acts as a treatment for the elimination of microbial bioburden on cannabis and hemp flowers.

  • PR Newswire

    Digipath Announces Results for the Fiscal Third Quarter 2019, Revenues Grow 25% Year Over Year

    Revenue Growth Comes as New Potential Revenue Lines Move into Beta Testing LAS VEGAS , Aug. 13, 2019 /PRNewswire/ --  Digipath, Inc.   (OTCQB: DIGP) ("DIGP" or the "Company"), a service-oriented ...

  • PR Newswire

    Digipath Reports Significant Progress on GroSciences' Tru-Hemp ID Kit

    LAS VEGAS, July 29, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP) ("DIGP" or the "Company"), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that the Company's GroSciences subsidiary has made significant progress in developing its Tru-Hemp ID project, with commercial availability targeted for late 2019/early 2020. GroSciences is Digipath's wholly owned subsidiary which combines years of testing data and proprietary research to create "The Science to Succeed" for clients wanting expert guidance on formulations, identification, and more. As previously reported, Digipath, via GroSciences, has been developing a field testing kit for hemp, cannabis and other related products with a myriad of applications from law enforcement to growers.

  • ACCESSWIRE

    Digipath, Inc. Joins The Stock Day Podcast to Discuss their Expansion into Columbia

    PHOENIX, AZ / ACCESSWIRE / July 18, 2019 / The Stock Day Podcast welcomed Digipath, Inc. (DIGP) (“the Company”), a service-oriented independent testing laboratory, data analytics, and formulation firm focused on the developing cannabis and hemp markets. CEO and Founder, Todd Denkin, joined Stock Day host Everett Jolly. Jolly began the interview by asking about the Company’s recent announcement of a field test for cannabis versus hemp identification for law enforcement.

  • PR Newswire

    Digipath CEO Todd Denkin Interviewed by CEO Roadshow

    LAS VEGAS, July 16, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP) ("DIGP" or the "Company"), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that Company CEO Todd Denkin was recently interviewed by CEO Roadshow with veteran journalist Mike Elliott. In this interview, Denkin discusses the Company's recent provisional patent applications involving terpene technology. "It's always a pleasure to sit down with Mr. Elliott, who is a true professional with a significant following," stated Todd Denkin, CEO, Digipath Inc. "In this interview we covered some of the more exciting things happening for Digipath and its shareholders.

  • PR Newswire

    Digipath's Dr. Cindy Orser Featured in Forbes Article on Cannabis Strains/Cultivars

    The article, written by Forbes contributor Andre Bourque, addresses the messy nomenclature of the current cannabis market wherein an imprecise system of non-scientific names is used to identify and sell cannabis strains, or more accurately cannabis cultivars. Mr. Bourque refers to Dr. Orser and her colleague Dr. Philippe Henry's assertion that "the cannabis consumer patient often times has no real idea of the composition, consistency or comparability of the cannabis product that they purchase," in their previous peer-reviewed publication "Making Sense of Cannabis Strains through Chemometrics," in Cannabis Science & Technology.

  • PR Newswire

    Digipath Benefits from Record Cannabis Sales in Nevada

    This corresponds with the increased demand Digipath is experiencing for its governmentally required cannabis testing services in Nevada. In March alone, the State of Nevada reported record cannabis sales of just under $60 million. Recreational sales were $53.6 million, up $11.1 million from February, while medicinal sales were off by $800,000.

  • Digipath Announces Results for the Fiscal Second Quarter 2019
    PR Newswire

    Digipath Announces Results for the Fiscal Second Quarter 2019

    Revenues Continue to Rise Quarter Over Quarter LAS VEGAS , May 16, 2019 /PRNewswire/ --  Digipath, Inc.  (OTCQB: DIGP) ("DIGP" or the "Company"), a service-oriented independent testing ...

  • PR Newswire

    Digipath Agrees to Provide Lab Testing for One World Pharma in Colombia

    LAS VEGAS, May 1, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and hemp markets, is pleased to announce that it has entered into an agreement to provide pharmaceutical grade analysis and testing services to One World Pharma (OTC Pink OWPC), a Colombian cannabis producer, using compliant lab equipment and processes under ISO:17025 or similar guidelines that will meet all necessary Colombian and international standards. The agreement gives Digipath its first commercial customer in Colombia. One World Pharma is licensed to produce and manufacture raw cannabis and hemp plant ingredients for both medical and industrial uses in Colombia with significant approvals and Colombian relationships in place, including permission to cultivate 13 different THC strains.

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 4/19

    HOLLYWOOD, CA / ACCESSWIRE / April 19, 2019 / CBD business exploding, drinking water solutions, cannabis testing, gasoline prices; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally ...

  • PR Newswire

    In case you missed it: Digipath's Chief Science Officer Explains Company's New Field Test

    LAS VEGAS, April 17, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), is pleased to provide an opportunity to hear more about the Company's ground breaking new field test for cannabis, hemp and CBD samples via an interview with Chief Science Officer Cindy Orser. Dr. Orser, PhD and Dr. Philippe Henry, PhD are the driving forces behind the development of the field test which has been created to provide relief and clarity for an array of uses where the type of cannabis product must be quickly and accurately determined using a portable methodology. High Times recently reported an instance where a fully-compliant hemp shipment was wrongfully seized due to a failure to properly identify the cargo. The DEA is now looking for a field test to avoid such problems.

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 4/12

    HOLLYWOOD, CA / ACCESSWIRE / April 12, 2019 / Free wireless service, new hemp technology, water industry, hemp wine, acquisition mode, paycheck to paycheck; this week on MoneyTV with Donald Baillargeon. ...

  • ACCESSWIRE

    4/12, MoneyTV with Donald Baillargeon

    HOLLYWOOD, CA / ACCESSWIRE / April 12, 2019 / Free wireless service, new hemp technology, water industry, hemp wine, acquisition mode, paycheck to paycheck; this week on MoneyTV with Donald Baillargeon. ...

  • ACCESSWIRE

    Emerging Markets Report: Perfect Timing

    Industry publications like High Times havealready reported how confusion and uncertainty by law enforcement in identifying what type of cannabis plant they are examining has led to arrests and confiscations for what was legal hemp. In late February, as Drs. Orser and Henry were putting the final touches on the joint provisional patent application, the United States Drug Enforcement Agency put out a Requestfor Proposal (RFP) for a field testing kit. A simple review of Digipath's patent application reads as if the DEA was reading their minds.

  • PR Newswire

    Digipath Files Patent Application for Test to Distinguish Hemp from Drug-type Cannabis

    LAS VEGAS, April 9, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and hemp markets, is pleased to announce that in collaboration with VSSL of Kelowna, BC, has filed a provisional patent application for a Field Testing Kit that can quickly determine whether a plant sample is actually hemp, drug-type THC or drug-type CBD. Currently the only recourse for law enforcement to make a determination of what is being transported across state lines is lab based analytical testing of the mature plants for their THC content to come in under the 0.3% THC level. The Digipath-VSSL simple genetic field test will allow for a DNA-based assay to clearly designate if plant material at any stage of growth is industrial hemp or drug-type CBD and NOT drug-type THC.

  • GlobeNewswire

    Hemp, Inc.’s 1st West Coast Hemp University is a Huge Success

    SPRING HOPE, NC, March 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Hemp, Inc. (OTC PINK: HEMP) is pleased to announce the huge success of its 1st Hemp University educational seminar on the west coast, in Ashland, Oregon. Held this past weekend (Saturday, March 23, 2019) at Southern Oregon University, the sold-out event provided attendees with a full day of networking, education, and support. As a global leader in the industrial hemp industry with bi-coastal processing centers including a state of the art hemp processing center in Medford, Oregon, the 85,000 square-foot multipurpose industrial hemp processing facility in Spring Hope, North Carolina, and a 500-acre hemp growing Eco-Village in Golden Valley, Arizona, one of Hemp, Inc.’s missions has been to revive family farms and small businesses in the hemp industry.

  • GlobeNewswire

    Hemp, Inc. CEO Bruce Perlowin Recognized as Man of the Year for Outstanding Achievement in the American Hemp Industry

    SPRING HOPE, NC, March 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers including the 85,000 square-foot multipurpose industrial hemp processing facility in Spring Hope, North Carolina, a state of the art processing center in Medford, Oregon, and a 500-acre hemp growing Eco-Village in Golden Valley, Arizona, announced today Hemp, Inc. CEO, Bruce Perlowin accepted The First Annual Hemp Awards recognition as “Man of the Year” for 2018, at the ASD Market Week show in Las Vegas. The award comes from his outstanding achievement in ‘The American Hemp Industry’. The award demonstrated the amount of increased recognition the hemp industry is continuing to receive and reflects the demand for leaders within this space is recognized.

  • PR Newswire

    Digipath's Orser and Denkin to Present at Hemp University

    LAS VEGAS, March 21, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and hemp markets, is pleased to announce that its CEO and Founder Todd Denkin and its Chief Science Officer Dr. Cindy Orser have been asked to present at the Hemp University symposium March 23, 2019 on the campus of Southern Oregon University. The event is hosted by Hemp, Inc. (HEMP) and brings together some of the leading minds in hemp to educate, support and build community for hemp farmers and entrepreneurs.

  • PR Newswire

    Digipath Featured in CannaInvestor Magazine

    LAS VEGAS, March 19, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and hemp markets, is pleased to announce that it is the featured company in the most recent edition of CANNAINVESTOR Magazine, with comprehensive coverage of the Company's business model and accomplishments. "CANNAINVESTOR Magazine presents us with a tremendous opportunity to share the Digipath story with an ideal audience of investors who have a proven interest in better cannabis public companies," stated Todd Denkin, CEO, Digipath, Inc. "It is quite literally the ideal demographic and I strongly encourage any current or prospective investor to read through the presentation. Digipath, Inc. supports the cannabis industry's best practices for reliable testing, data acquisition, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry. Digipath Labs provides pharmaceutical-grade analysis and testing to the cannabis industry to ensure producers, consumers, and patients know exactly what is in the cannabis they ingest and to help maximize the quality of its client's products through analysis, research, development, and standardization.

  • GlobeNewswire

    Hemp, Inc. Subsidiary, The Hemp University, Announces its First West Coast, All Day Seminar in Ashland, Oregon

    SPRING HOPE, NC, March 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers including the 85,000 square-foot multipurpose industrial hemp processing facility in Spring Hope, North Carolina, a state of the art processing center in Medford, Oregon, and a 500-acre hemp growing Eco-Village in Golden Valley, Arizona, announced today the first Oregon-based Hemp University educational seminar will take place at Southern Oregon University in Ashland, on March 23, 2019. This full day of education, support and networking will be located just 13 miles from Hemp, Inc.’s sophisticated Local Processing Center in Medford, Oregon, which focuses on hemp flower harvesting, drying, curing, chucking, trimming, storing and post-processing for cannabidiol (CBD).

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 3/15

    HOLLYWOOD, CA / ACCESSWIRE / March 15, 2019 / Disrupting the water industry, battling the opioid crisis, terpenes' many uses, high-end CBD products, NASDAQ application, audio PRs,, socialism vs. capitalism ...

  • ACCESSWIRE

    SmallCap Sentinel: Patents and the Power of the Terpenes

    Terpenes, a name we suspect you will start hearing more and more often, are the major components of plant derived essential oils and have been used by humans for thousands of years (think aromatherapy). Terpenes are another category of chemicals made by most plants, including cannabis where they play the major factor in how THC or CBD affect a person withstandalone activity of their own. The first patent announcement gives Digipath a potential presence in the emerging cannabis beverage market.

  • PR Newswire

    Digipath Files Provisional Patent for New Discovery in Terpene Technology

    LAS VEGAS, March 11, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and hemp markets, is pleased to announce that it has filed a United States provisional patent application for "A METHOD OF DETERMINING TERPENE-BASED BIOCONTROL AGENTS FOR CANNABIS AND HEMP." This application relates to a method of using natural, plant based, non-toxic compounds instead of chemical pesticides in cannabis and hemp cultivation. Terpenes are major components of plant derived essential oils and have been used by humans for thousands of years.  Natural terpenes play a critical role in a plant's interaction with its environment, including repelling pests and attracting pollinators.  Mold presents a difficult problem for many cannabis cultivators, resulting in a failure rate of approximately 10% for flower harvests in Nevada, with higher failure rates in California.

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 3/8

    HOLLYWOOD, CA / ACCESSWIRE / March 8, 2019 / Cannabis industry milestone, solar lending tree, concealed carry patent, middle east water solutions, 2020 POTUS logjam; this week on MoneyTV with Donald Baillargeon. ...